Processa Pharmaceuticals (PCSA) has released an update to notify the public and investors about a regulation fd disclosure.
The Company announced the pricing of its Offering on January 26, 2024, through a press release which is provided with the current report.
For further insights into PCSA stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
